Correlation with dROMs levels.

<p>Correlation with dROMs levels.</p

Correlation with Log hsCRP levels.

<p>Correlation with Log hsCRP levels.</p

Clinical characteristics of all subjects.

<p>Clinical characteristics of all subjects.</p

Correlation with Log Fstl1 levels.

<p>Correlation with Log Fstl1 levels.</p

Correlation between plasma Fstl1 levels and clinical parameters.

<p>Correlation of plasma Log Fstl1 levels with Log fasting immune-reactive insulin (FIRI), Log high sensitive CRP (hsCRP) and derivatives of reactive oxidative metabolites (dROMs) was analyzed.</p

Clinical characteristics of control subjects and CAD patients.

<p>Data are presented as mean ± SE.</p><p>BMI; body mass index, BP; blood pressure, LDL; low density lipoprotein.</p><p>HDL; high density lipoprotein, eGFR; estimated glomerular filtration rate.</p><p>CTRP1; C1q/TNF-related protein-1.</p

Plasma CTRP1 levels in control subjects and patients with CAD.

<p>Plasma concentration of CTRP1 in control subjects (n = 64) and CAD patients (n = 76) was measured by ELISA system.</p

Correlation between plasma CTRP1 levels and clinical parameters.

<p>BMI; body mass index, BP; blood pressure, LDL; low density lipoprotein.</p><p>HDL; high density lipoprotein, eGFR; estimated glomerular filtration rate.</p

Correlation between plasma CTRP1 levels and conventional risk factors.

<p>Correlation analyses between plasma CTRP1 levels and risk factors, including body mass index (BMI), systolic blood pressure (BP), high density lipoprotein (HDL) cholesterol, triglyceride and adiponectin levels were evaluated.</p

Association with CAD.

<p>The odds ratios corresponding to a 1 SD increase in each measure of the indicated parameters were estimated. SD; standard deviation, CI; confidence intervals, BMI; body mass index, BP; blood pressure, LDL; low density lipoprotein, HDL; high density lipoprotein, eGFR; estimated glomerular filtration rate, CTRP1; C1q/TNF-related protein 1.</p